Asthma, Aspirin-Induced
Information
- Disease name
- Asthma, Aspirin-Induced
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03028350 | Active, not recruiting | Phase 2 | Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) | July 17, 2017 | August 2024 |
| NCT01597375 | Completed | Phase 2 | Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin) | August 31, 2012 | December 14, 2016 |
| NCT03326063 | Completed | Phase 2 | Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban | April 26, 2018 | April 15, 2023 |
| NCT01867281 | Completed | Phase 4 | The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases | June 2013 | June 2014 |
| NCT02824523 | Completed | Role of Inflammatory Mediators in AERD | July 2016 | May 1, 2021 | |
| NCT05575037 | Recruiting | Phase 2 | Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease | August 1, 2023 | April 30, 2026 |
| NCT04823585 | Recruiting | N/A | Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab) | August 12, 2021 | December 31, 2025 |
| NCT01320072 | Terminated | Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease | May 2010 | May 26, 2022 | |
| NCT01681615 | Unknown status | N/A | Challenge Test for Acetylsalicylic Acid Hypersensitivity | September 2012 | December 2013 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D055963